Table 3. Activities of the IAP-addressing CDK4/6 degrader.
![]() | |||||||
Cmpd | Linker | X | Y | elog D7.4 a | D CDK4 b |
D
CDK6
b
|
|
0.1 μM | 0.1 μM | 1 μM | |||||
5 | — | — | — | n.d. c | n.d. | n.d. | n.d. |
8 (BSJ) | — | — | — | 2.5 | 27 | 5.5 | 2.1 |
35 |
![]() |
Me | H | 4.3 | 77 | 75 | 18 |
36 |
![]() |
H | Me | 4.5 | >95 | >95 | n.d. |
aExperimental distribution coefficient at pH 7.4.
bCDK4 or CDK6 degradation indicated as remaining CDK4 or CDK6 levels after 16 h treatment of each compound at the indicated concentration. Percentage values are normalized to DMSO-treated MM.1S cells and the respective loading controls (100%). All of the data were the average of at least three independent experiments.
cNot determined.